Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR maze training aims to boost navigation skills in older adults with memory issues

NCT ID NCT07225400

Symptom relief Sponsor: Albert Einstein College of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This study tests whether older adults with mild cognitive impairment can complete a 4-month virtual reality maze training program. Participants will wear VR goggles and navigate through 50 different mazes while their brain activity is recorded with EEG. The goal is to see if this training improves their real-world navigation skills and to measure brain changes associated with learning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Spatial navigation training in virtual reality
What this could lead to
If successful, this could point toward a non-drug, at-home training method to help people with mild cognitive impairment maintain their navigation skills and independence.
What could go wrong
This is a very early, small study (30 people) with no control group, so results may not apply widely. The training is demanding (24 sessions over 4 months), and some participants may not complete it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 and older with amnestic mild cognitive impairment (aMCI); * Can speak English; * Agrees to MoBI recording; * Normal or corrected-to-normal vision/audition; * Able to walk unassisted for 10 minutes; * Plan to be in the area for next year Exclusion Criteria: * Dementia (Memory Impairment/AD8 screen); * Medical conditions that affect participation such as vertigo and neck pain; * Hospitalization in the past six months or plans for surgery affecting participation in the next four months; * Mobility limitations solely due to musculoskeletal limitation or pain; * Terminal illness with life expectancy less than 12 months; * Presence of clinical disorders that overtly alter attention like delirium; * Active psychoses or psychiatric symptoms; * Living in nursing home; * Participation in intervention trial; * Standard contraindications to EEG including seizure medication, epilepsy, stroke, traumatic brain injury; * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mild cognitive impairment (MCI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mild cognitive impairment (MCI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Albert Einstein College of Medicine

    RECRUITING

    The Bronx, New York, 10461, United States

  • Columbia University Irving Medical Center

    RECRUITING

    Manhattan, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.